Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Publikationen aller KHFI Mitglieder 2011-2015 (Stand 01.06.2015) 2015 (38) 1. Akashi YJ, Nef HM, Lyon AR. Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol. 2015 Apr 7: In press. 2. Baker JO, Tyther R, Liebetrau C, Clark J, Howarth R, Patterson T, Möllmann H, Nef H, Sicard P, Kailey B, Devaraj R, Redwood SR, Kunst G, Weber E, Marber MS. Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury. Basic Res Cardiol. 2015 May; 110(3): 478. 3. Bandorski D, Bogossian H, Braun O, Frommeyer G, Zarse M, Holtgen R, Liebetrau C. Patients with atrial fibrillation complicated by coronary artery disease : Is a single value of sensitive cardiac troponin I on admission enough? Herzschrittmacherther Elektrophysiol. 2015 Mar; 26(1): 39-44. 4. Bauer T, Hochadel M, Brachmann J, Schächinger V, Boekstegers P, Zrenner B, Zahn R, Zeymer U. Use and outcome of radial versus femoral approach for primary PCI in patients with acute ST elevation myocardial infarction without cardiogenic shock: Results from the ALKK PCI registry. Catheter Cardiovasc Interv. 2015 May 6: In press. 5. Bestehorn K, Bauer T, Fleck E, Bestehorn M, Pauletzki J, Hamm C. Coronary procedures in German hospitals: a detailed analysis for specific patient clusters. Clin Res Cardiol. 2015 Jan 28: In press. 6. Blumenstein J, Kim WK, Liebetrau C, Gaede L, Kempfert J, Walther T, Hamm C, Möllmann H. Challenges of coronary angiography and intervention in patients previously treated by TAVI. Clin Res Cardiol. 2015 Feb 27: In press. 7. Boeder NF, Schmitt J, Rixe J, Nef HM. Trapped cardioverter-defibrillator lead after interventional closure of an iatrogenic atrial septal defect after catheter-based mitral valve repair with the MitraClip(R) system. Int J Cardiol. 2015 Feb 25; 184C: 412-413. 8. Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Munzel T, Tamburino C. Percutaneous coronary intervention with everolimuseluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention. 2015 Feb; 10(10): 114453. 9. Dörr O, Ewen S, Liebetrau C, Möllmann H, Gaede L, Linz D, Hohl M, Troidl C, Bauer T, Böhm M, Hamm C, Mahfoud F, Nef H. Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation. Clin Res Cardiol. 2015 May 26: In press. 10. Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Haidner V, Wiebe J, Voss S, Bauer T, Hamm C, Nef H. Brain-Derived Neurotrophic Factor as a Marker for Immediate Assessment of the Success of Renal Sympathetic Denervation. J Am Coll Cardiol. 2015 Mar 24; 65(11): 1151-3. 11. Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Morczeck K, Wiebe J, Hoffmann J, Voss S, Bauer T, Hamm C, Nef H. Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis. Am J Hypertens. 2015 Mar 11: In press. 12. Dörr O, Liebetrau C, Möllmann H, Mahfoud F, Ewen S, Gaede L, Troidl C, Hoffmann J, Busch N, Laux G, Wiebe J, Bauer T, Hamm C, Nef H. Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension. Clin Res Cardiol. 2015 Oct 18; 104(2): 175-184. 13. Dörr O, Liebetrau C, Wiebe J, Hecker F, Rixe J, Möllmann H, Hamm C, Nef H. Bioresorbable scaffolds for the treatment of in-stent restenosis. Heart Vessels. 2015 Jan 4; 30(2): 265-269. 14. Hoffmann J, Shmeleva EV, Boag SE, Fiser K, Bagnall A, Murali S, Dimmick I, Pircher H, Martin-Ruiz C, Egred M, Keavney B, von Zglinicki T, Das R, Todryk S, Spyridopoulos I. Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients. Circ Res. 2015 Jan 2; 116(1): 87-98. 15. Kempfert J, Meyer A, Kim WK, Van Linden A, Arsalan M, Blumenstein J, Möllmann H, Walther T. Comparison of two valve systems for transapical aortic valve implantation: a propensity scorematched analysis. Eur J Cardiothorac Surg. 2015 Feb 10: In press. 16. Kim WK, Kempfert J, Walther T, Möllmann H. Transfemoral valve-in-valve implantation of a St. Jude Medical Portico in a failing trifecta bioprosthesis: a case report. Clin Res Cardiol. 2015 Apr; 104(4): 363-5. 17. Kim WK, Rolf A, Möllmann H. Reply: Could Late Enhancement and Need for Permanent Pacemaker Implantation in Patients Undergoing TAVR Be Explained by Undiagnosed Transthyretin Cardiac Amyloidosis? J Am Coll Cardiol. 2015 Jan 27; 65(3): 312-3. 18. Kuck KH, Eggebrecht H, Figulla HR, Haude M, Katus H, Möllmann H, Naber CK, Schunkert H, Thiele H, Hamm C. Qualitätskriterien zur Durchführung der transvaskulären Aortenklappenimplantation (TAVI). Der Kardiologe. 2015 2014/12/06; 9(1): 11-26. 19. Liebetrau C, Hoffmann J, Dörr O, Gaede L, Blumenstein J, Biermann H, Pyttel L, Thiele P, Troidl C, Berkowitsch A, Rolf A, Voss S, Hamm CW, Nef H, Möllmann H. Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction. Circ Res. 2015 Feb 27; 116(5): 867-75. 20. Liebetrau C, Hoffmann J, Nef H, Möllmann H. Response to Letter Regarding Article, "Revisiting the Role of sCD40L as an Inflammatory Biomarker in a Clinical Model of Acute Myocardial Infarction". Circ Res. 2015 Feb 13; 116(4): e27. 21. Möllmann H, Kim WK, Kempfert J, Walther T, Hamm C. Complications of transcatheter aortic valve implantation (TAVI): how to avoid and treat them. Heart. 2015 Feb 6: In press. 22. Opolski MP, Achenbach S, Schuhback A, Rolf A, Möllmann H, Nef H, Rixe J, Renker M, Witkowski A, Kepka C, Walther C, Schlundt C, Debski A, Jakubczyk M, Hamm CW. Coronary Computed Tomographic Prediction Rule for Time-Efficient Guidewire Crossing Through Chronic Total Occlusion: Insights From the CT-RECTOR Multicenter Registry (Computed Tomography Registry of Chronic Total Occlusion Revascularization). JACC Cardiovasc Interv. 2015 Feb; 8(2): 257-67. 23. Opolski MP, Kim W, Liebetrau C, Walther C, Blumenstein J, Gaede L, Kempfert J, Van Linden A, Walther T, Hamm CW, Möllmann H. Diagnostic accuracy of computed tomography angiography for the detection of coronary artery disease in patients referred for transcatheter aortic valve implantation. Clin Res Cardiol. 2015 Jan 6: In press. 24. Parahuleva MS, Burgazli M, Langanke E, Dorr O, Parviz B, Mericliler M, Parahuleva N, Holschermann H, Erdogan A. Monocyte CD40 expression in young healthy female smokers and/or oral contraceptives users without additional risk factors for atherosclerosis. Thromb Res. 2015 Feb; 135(2): 260-6. 25. Pelliccia F, Parodi G, Greco C, Antoniucci D, Brenner R, Bossone E, Cacciotti L, Capucci A, Citro R, Delmas C, Guerra F, Ionescu CN, Lairez O, Larrauri-Reyes M, Lee PH, Mansencal N, Marazzi G, Mihos CG, Morel O, Nef HM, Nunez Gil IJ, Passaseo I, Pineda AM, Rosano G, Santana O, Schneck F, Song BG, Song JK, Teh AW, Ungprasert P, Valbusa A, Wahl A, Yoshida T, Gaudio C, Kaski JC. Comorbidities Frequency in Takotsubo Syndrome: An International Collaborative Systematic Review Including 1,109 Patients. Am J Med. 2015 Feb 3: In press. 26. Rohrbach S, Troidl C, Hamm C, Schulz R. Ischemia and reperfusion related myocardial inflammation: A network of cells and mediators targeting the cardiomyocyte. IUBMB Life. 2015 Apr 8: In press. 27. Rolf A, Rixe J, Kim WK, Guth S, Korlings N, Möllmann H, Nef HM, Liebetrau C, Krombach G, Kramm T, Mayer E, Hamm CW. Pulmonary vascular remodeling before and after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a cardiac magnetic resonance study. Int J Cardiovasc Imaging. 2015 Mar; 31(3): 613-9. 28. Schächinger V, Nef H, Achenbach S, Butter C, Deisenhofer I, Eckardt L, Eggebrecht H, Kuon E, Levenson B, Linke A, Madlener K, Mudra H, Naber CK, Rieber J, Rittger H, Walther T, Zeus T, Kelm M. Arbeitsanweisung in Herzkatheterlabor und Hybridoperationssaal. Der Kardiologe. 2015 2015(1): 29-34. 29. Schreckenberg R, Dyukova E, Sitdikova G, Abdallah Y, Schlüter KD. Mechanisms by which calcium receptor stimulation modifies electromechanical coupling in isolated ventricular cardiomyocytes. Pflugers Arch. 2015 Feb; 467(2): 379-88. 30. Schuhbaeck A, Weingartner C, Arnold M, Schmid J, Pflederer T, Marwan M, Rixe J, Nef H, Schneider C, Lell M, Uder M, Ensminger S, Feyrer R, Weyand M, Achenbach S. Aortic annulus eccentricity before and after transcatheter aortic valve implantation: Comparison of balloonexpandable and self-expanding prostheses. Eur J Radiol. 2015 Apr 18: In press. 31. Tamburino C, Latib A, van Geuns RJ, Sabate M, Mehilli J, Gori T, Achenbach S, Pan Alvarez M, Nef H, Lesiak M, Di Mario C, Colombo A, Naber CK, Caramanno G, Capranzano P, Brugaletta S, Geraci S, Araszkiewicz A, Mattesini A, Pyxaras SA, Rzeszutko L, Depukat R, Diletti R, Boone E, Capodanno D, Dudek D. Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective. EuroIntervention. 2015 Jan 21; 10(10). 32. Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H, Schneider S, Ebelt H, Werdan K, Zeymer U. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J. 2015 Apr; 169(4): e7-8. 33. Van Aelst LN, Voss S, Carai P, Van Leeuwen R, Vanhoutte D, Sanders-van Wijk S, Eurlings L, Swinnen M, Verheyen FK, Verbeken E, Nef H, Troidl C, Cook SA, Brunner-La Rocca HP, Möllmann H, Papageorgiou AP, Heymans S. Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening. Circ Res. 2015 Jan 30; 116(3): 425-36. 34. Walther T, Hamm CW, Schuler G, Berkowitsch A, Kötting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, Lange R, Kuck KH, Mohr FW, Möllmann H. Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol. 2015 Mar 10: In press. 35. Wiebe J, Bauer T, Dörr O, Möllmann H, Hamm CW, Nef HM. Implantation of a novolimuseluting bioresorbable scaffold with a strut thickness of 100 microm showing evidence of selfcorrection. EuroIntervention. 2015 Feb 6: In press. 36. Wiebe J, Hamm C, Nef H. A true bifurcational stenosis treated with a bioresorbable vascular scaffold and a drug-eluting metallic stent: Degradable meets durable. Catheter Cardiovasc Interv. 2015 Jan 10: In press. 37. Wiebe J, Liebetrau C, Dörr O, Most A, Weipert K, Rixe J, Bauer T, Möllmann H, Elsässer A, Hamm CW, Nef HM. Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion. Int J Cardiol. 2015 Jan 20; 179: 90-4. 38. Wiebe J, Rixe J, Nef H. Percutaneous closure of a hemodynamically significant connection between the inferior vena cava and the left atrium. Catheter Cardiovasc Interv. 2015 Jan 9: In press. 2014 (44) 39. Aslam M, Tanislav C, Troidl C, Schulz R, Hamm C, Gündüz D. cAMP controls the restoration of endothelial barrier function after thrombin-induced hyperpermeability via Rac1 activation. Physiol Rep. 2014 Oct 1; 2(10): e12175. 40. Bauer P, Koshty A, Hamm CW, Gündüz D. Ultrasound guided percutaneous thrombin injection in a radial artery pseudoaneurysm following percutaneous coronary intervention. Clin Res Cardiol. 2014 Jul 22; 103(12): 1022-4. 41. Bauer T. [When to stop dual antiplatelet treatment after PCI?--Cessation of dual antiplatelet treatment only under specific conditions]. Dtsch Med Wochenschr. 2014 Jan; 139(4): 126. 42. Bauer T, Hamm C. Akutes Koronarsyndrom und antithrombozytäre Therapie - Prähospitale Phase: nichts, ASS oder...? Herz. 2014 39(7): 803-807. 43. Bauer T, Linke A, Sievert H, Kahlert P, Hambrecht R, Nickenig G, Hauptmann KE, Sack S, Gerckens U, Schneider S, Zeymer U, Zahn R. Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the German TAVI Registry). Am J Cardiol. 2014 Feb 1; 113(3): 518-21. 44. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, Breault D, Richardson G, von Zglinicki T, Saretzki G, Spyridopoulos I. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014 Oct; 236(2): 312-20. 45. Daniel JM, Penzkofer D, Teske R, Dutzmann J, Koch A, Bielenberg W, Bonauer A, Boon RA, Fischer A, Bauersachs J, van Rooij E, Dimmeler S, Sedding DG. Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury. Cardiovasc Res. 2014 Sep 1; 103(4): 564-72. 46. Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Rixe J, Hamm C, Nef H. Soluble fms-Like Tyrosine Kinase-1 and Endothelial Adhesion Molecules (Intercellular Cell Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1) as Predictive Markers for Blood Pressure Reduction After Renal Sympathetic Denervation. Hypertension. 2014 Jan 27; 63(5): 984-90. 47. Feustel A, Hahn A, Schneider C, Sieweke N, Franzen W, Gündüz D, Rolfs A, Tanislav C. Continuous cardiac troponin I release in Fabry disease. PLoS One. 2014 9(3): e91757. 48. Fischer-Rasokat U, Honold J, Lochmann D, Liebetrau C, Leick J, Hamm C, Fichtlscherer S, Möllmann H, Spyridopoulos I. Ivabradine therapy to unmask heart rate-independent effects of beta-blockers on pulse wave reflections. Clin Res Cardiol. 2014 Jun; 103(6): 487-94. 49. Hamm CW, Liebetrau C. Revaskularisationsoptionen bei stabiler KHK – pro PCI. Aktuel Kardiol. 2014 //05.11.2014; 3(05): 301-304. 50. Hamm CW, Möllmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Mohr FW. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J. 2014 Jun 21; 35(24): 1588-98. 51. Hoffmann J, Ospelt M, Troidl C, Voss S, Liebetrau C, Kim WK, Rolf A, Wietelmann A, Braun T, Troidl K, Sadayappan S, Barefield D, Hamm C, Nef H, Möllmann H. Sham Surgery and InterIndividual Heterogeneity Are Major Determinants of Monocyte Subset Kinetics in a Mouse Model of Myocardial Infarction. PLoS One. 2014 9(6): e98456. 52. Hoffmann J, Spyridopoulos I. Senescent cytotoxic T cells in acute myocardial infarction: innocent bystanders or the horsemen of apocalypse? Cell Mol Immunol. 2014 Sep 22: In press. 53. Kastaun S, Gerriets T, Yeniguen M, Nef H, Moellmann H, Sammer G, Juenemann M. Locus of control and stress management strategies in women with takotsubo cardiomyopathy. Int J Cardiol. 2014 Dec 15; 177(2): 658-60. 54. Kastaun S, Schwarz NP, Juenemann M, Yeniguen M, Nef HM, Moellmann H, Hamm CW, Sammer G, Hennig J, Bachmann G, Gerriets T. Cortisol awakening and stress response, personality and psychiatric profiles in patients with takotsubo cardiomyopathy. Heart. 2014 Nov 15; 100(22): 1786-92. 55. Kempfert J, Meyer A, Kim WK, van Linden A, Arsalan M, Blumenstein J, Möllmann H, Walther T. First experience without pre-ballooning in transapical aortic valve implantation: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2014 Mar 27: In press. 56. Kim WK, Rolf A, Liebetrau C, Van Linden A, Blumenstein J, Kempfert J, Bachmann G, Nef H, Hamm C, Walther T, Möllmann H. Detection of Myocardial Injury by CMR After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2014 Jul 29; 64(4): 349-57. 57. Kuster DW, Cardenas-Ospina A, Miller L, Liebetrau C, Troidl C, Nef HM, Möllmann H, Hamm CW, Pieper KS, Mahaffey KW, Kleiman NS, Stuyvers BD, Marian AJ, Sadayappan S. Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury. Am J Physiol Heart Circ Physiol. 2014 Feb; 306(4): H547-56. 58. Lauten A, Figulla HR, Möllmann H, Holzhey D, Kötting J, Beckmann A, Veit C, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr FW, Hamm CW. TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY). EuroIntervention. 2014 Nov 20; 10(7): 850-9. 59. Ledwoch J, Franke J, Baldus S, Schillinger W, Bekeredjian R, Boekstegers P, Hink U, Kuck KH, Ouarrak T, Möllmann H, Nickenig G, Senges J, Franzen O, Sievert H. Impact of the learning curve on outcome after transcatheter mitral valve repair: results from the German Mitral Valve Registry. Clin Res Cardiol. 2014 Jun 13; 103(11): 930-7. 60. Liebetrau C, Gaede L, Doerr O, Blumenstein J, Rixe J, Teichert O, Willmer M, Weber M, Rolf A, Möllmann H, Hamm C, Nef H. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention. Scand J Clin Lab Invest. 2014 Dec 5; 74(2): 81-8. 61. Liebetrau C, Gaede L, Dörr O, Hoffmann J, Wolter JS, Weber M, Rolf A, Hamm CW, Nef HM, Möllmann H. High-sensitivity cardiac troponin T and copeptin assays to improve diagnostic accuracy of exercise stress test in patients with suspected coronary artery disease. Eur J Prev Cardiol. 2014 Apr 3: In press. 62. Liebetrau C, Gaede L, Dörr O, Troidl C, Voss S, Hoffmann J, Paszko A, Weber M, Rolf A, Hamm C, Nef H, Möllmann H. Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction. Clin Chim Acta. 2014 Feb 15; 429: 34-7. 63. Liebetrau C, Möllmann H, Troidl C, Nef H. Reply: Effects of Heparin on Temporal MicroRNA Profiles. J Am Coll Cardiol. 2014 Nov 25; 63(9): 941-942. 64. Liebetrau C, Nef HM, Dörr O, Gaede L, Hoffmann J, Hahnel A, Rolf A, Troidl C, Lackner KJ, Keller T, Hamm CW, Möllmann H. Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction. Heart. 2014 Apr; 100(8): 652-7. 65. Liebetrau C, Nef HM, Hamm CW. Troponin: more lessons to learn. Eur Heart J. 2014 Sep 10; 35(6): 338-40. 66. Meredith IT, Teirstein PS, Bouchard A, Carrie D, Möllmann H, Oldroyd KG, Hall J, Allocco DJ, Dawkins KD, Stone GW. Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM Trial). Am J Cardiol. 2014 Apr 1; 113(7): 1117-23. 67. Möckel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C, Müller C, Müller R, Peitsmeyer P, von Recum J, Tajsic M, Vollert JO, Giannitsis E. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J. 2014 Apr 30: In press. 68. Mohr FW, Holzhey D, Möllmann H, Beckmann A, Veit C, Figulla HR, Cremer J, Kuck KH, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Hamm CW. The German Aortic Valve Registry: 1-year results from 13 680 patients with aortic valve disease. Eur J Cardiothorac Surg. 2014 Nov; 46(5): 808-16. 69. Möllmann H, Kim WK, Kempfert J, Blumenstein J, Liebetrau C, Nef H, Van Linden A, Walther T, Hamm C. Transfemoral Aortic Valve Implantation of Edwards SAPIEN XT Without Predilatation Is Feasible. Clin Cardiol. 2014 Jul 31; 37(11): 667-71. 70. Nef H, Möllmann H, Elsässer A, Hamm C. Sind neue diagnostische Verfahren hilfreich? CardioVasc. 2014 2014/06/01; 14(3): 48-50. 71. Rackauskas G, Saygili E, Rana OR, Saygili E, Gemein C, Laucevicius A, Aidietis A, Marinskis G, Serpytis P, Plisiene J, Pauza DH, Schauerte P. Sub-threshold high frequency electrical field stimulation induces VEGF expression in cardiomyocytes. Cell Transplant. 2014 Jul 8: In press. 72. Renker M, Schoepf UJ, Wang R, Meinel FG, Rier JD, Bayer RR, 2nd, Möllmann H, Hamm CW, Steinberg DH, Baumann S. Comparison of diagnostic value of a novel noninvasive coronary computed tomography angiography method versus standard coronary angiography for assessing fractional flow reserve. Am J Cardiol. 2014 Nov 1; 114(9): 1303-8. 73. Rohrbach S, Aslam M, Niemann B, Schulz R. Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects. Br J Pharmacol. 2014 Jun; 171(12): 2964-92. 74. Rolf A, Rixe J, Kim WK, Borgel J, Möllmann H, Nef HM, Liebetrau C, Kramm T, Guth S, Krombach GA, Mayer E, Hamm CW. Right ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary hypertension before and after successful pulmonary endarterectomy - a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014 16: 96. 75. Sajjad A, Novoyatleva T, Vergarajauregui S, Troidl C, Schermuly RT, Tucker HO, Engel FB. Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis. Biochim Biophys Acta. 2014 Nov; 1843(11): 2556-62. 76. Savai R, Al-Tamari HM, Sedding D, Kojonazarov B, Muecke C, Teske R, Capecchi MR, Weissmann N, Grimminger F, Seeger W, Schermuly RT, Pullamsetti SS. Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension. Nat Med. 2014 Nov; 20(11): 1289-300. 77. Schuhbaeck A, Achenbach S, Pflederer T, Marwan M, Schmid J, Nef H, Rixe J, Hecker F, Schneider C, Lell M, Uder M, Arnold M. Reproducibility of aortic annulus measurements by computed tomography. Eur Radiol. 2014 Aug; 24(8): 1878-88. 78. Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J, Hammerstingl C, Ojeda FM, Kim WK, Koschyk DH, Schirmer J, Baldus S, Grube E, Möllmann H, Reichenspurner H, Nickenig G, Blankenberg S, Diemert P, Treede H, Walther T, Werner N, Schnabel RB. Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol. 2014 Aug; 103(8): 631-40. 79. Van Linden A, Blumenstein J, Möllmann H, Kim WK, Walther T, Kempfert J. Image-based decision-making treatment of degenerated mitroflow and trifecta prostheses. Ann Thorac Surg. 2014 Nov; 98(5): 1809-13. 80. Van Linden A, Kempfert J, Blumenstein J, Möllmann H, Kim WK, Alkaya S, Hamm C, Walther T. Manual versus automatic detection of aortic annulus plane in a computed tomography scan for transcatheter aortic valve implantation screening. Eur J Cardiothorac Surg. 2014 Aug; 46(2): 20712. 81. Wiebe J, Möllmann H, Most A, Dörr O, Weipert K, Rixe J, Liebetrau C, Elsässer A, Achenbach S, Hamm C, Nef H. Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold. Clin Res Cardiol. 2014 Feb; 103(2): 141-8. 82. Wiebe J, Nef HM, Hamm CW. Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease. J Am Coll Cardiol. 2014 Dec 16; 64(23): 2541-2551. 2013 (48) 83. Aslam M, Schlüter KD, Rohrbach S, Rafiq A, Nazli S, Piper HM, Noll T, Schulz R, Gündüz D. Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase. J Physiol. 2013 Jan 15; 591(Pt 2): 461-73. 84. Aslam M, Sedding D, Koshty A, Santoso S, Schulz R, Hamm C, Gündüz D. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: Role of P2Y1 and P2Y12 receptors. Thromb Res. 2013 Nov; 132(5): 548-57. 85. Bauer T, Gitt AK, Hochadel M, Möllmann H, Nef H, Weidinger F, Zahn R, Hamm CW, Marco J, Zeymer U. Left circumflex artery-related myocardial infarction: Does ST elevation matter? Results from the Euro Heart Survey PCI registry. Int J Cardiol. 2013 Oct 15; 168(6): 5239-42. 86. Bauer T, Zeymer U, Hochadel M, Möllmann H, Weidinger F, Zahn R, Nef HM, Hamm CW, Marco J, Gitt AK. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry. Int J Cardiol. 2013 Jul 1; 166(3): 596-600. 87. Blumenstein J, Kempfert J, Kim W, Liebetrau C, Möllmann H, Walther T. Transapical access and closure devices: rationale and current status. Expert Rev Cardiovasc Ther. 2013 Dec; 11(12): 1613-7. 88. Blumenstein J, Kempfert J, Van Linden A, Arsalan M, Möllmann H, Kim WK, Walther T. Sutureless transapical access and closure to facilitate transapical transcatheter aortic valve implantation: first-in-human use. J Am Coll Cardiol. 2013 Aug 20; 62(8): 763. 89. Blumenstein J, Kempfert J, Van Linden A, Arsalan M, Schmidt SK, Möllmann H, Kim WK, Thourani V, Walther T. First-in-man evaluation of the transapical APICA ASC access and closure device: the initial 10 patients. Eur J Cardiothorac Surg. 2013 Apr 5; 44(6): 1057-1062. 90. Blumenstein J, Liebetrau C, Van Linden A, Moellmann H, Walther T, Kempfert J. Recent advances in transcatheter aortic valve implantation: novel devices and potential shortcomings. Curr Cardiol Rev. 2013 Nov; 9(4): 274-80. 91. Blumenstein J, Van Linden A, Kim WK, Skwara W, Schoenburg M, Arsalan M, Moellmann H, Niederhagen M, Kempfert J, Walther T. Early SAPIEN transcatheter heart valve dysfunction due to tissue ingrowth in an octogenarian. Clin Res Cardiol. 2013 Mar; 102(3): 237-40. 92. Blumenstein J, Van Linden A, Moellmann H, Walther T, Kempfert J. Transcatheter Heart Valves: Specific Characteristics and Potential Shortcomings. Curr Cardiol Rev. 2013 Dec 2: In press. 93. Blumenstein JM, Van Linden A, Moellmann H, Seeburger J, Rastan A, Kim WK, Mohr FW, Kempfert J, Walther T. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept. Thorac Cardiovasc Surg. 2013 Aug; 61(5): 409-13. 94. Cabrera-Fuentes HA, Aslam M, Saffarzadeh M, Kolpakov A, Zelenikhin P, Preissner KT, Ilinskaya ON. Internalization of Bacillus intermedius ribonuclease (BINASE) induces human alveolar adenocarcinoma cell death. Toxicon. 2013 Jul; 69: 219-26. 95. Dörr O, Hamm C, Nef HM. Single-side renal sympathetic denervation in a hypertensive patient with a single kidney. Am J Kidney Dis. 2013 Jun; 61(6): 1042-3. 96. Dörr O, Liebetrau C, Hecker F, Wiebe J, Möllmann H, Hamm C, Nef H. "Full bioresorbable jacket" : A new era has begun. Herz. 2013 Aug 2; 40(2): 255-256. 97. Dörr O, Liebetrau C, Möllmann H, Achenbach S, Sedding D, Szardien S, Willmer M, Rixe J, Troidl C, Elsässer A, Hamm C, Nef HM. Renal sympathetic denervation does not aggravate functional or structural renal damage. J Am Coll Cardiol. 2013 Jan 29; 61(4): 479-80. 98. Dörr O, Liebetrau C, Möllmann H, Rixe J, Hecker F, Szardien S, Willmer M, Hamm C, Nef HM. Influence of renal sympathetic denervation on quality of life. J Interv Cardiol. 2013 Oct; 26(5): 536-41. 99. Hoffmann R, Möllmann H, Lotfi S. Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated stenotic Sapien heart valve prosthesis. Catheter Cardiovasc Interv. 2013 Dec 1; 82(7): E922-5. 100. Kasseckert SA, Shahzad T, Miqdad M, Stein M, Abdallah Y, Scharbrodt W, Oertel M. The mechanisms of energy crisis in human astrocytes after subarachnoid hemorrhage. Neurosurgery. 2013 Mar; 72(3): 468-74; discussion 474. 101. Leick J, Liebetrau C, Szardien S, Fischer-Rasokat U, Willmer M, van Linden A, Blumenstein J, Nef H, Rolf A, Arlt M, Walther T, Hamm C, Möllmann H. Door-to-implantation time of extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac arrest. Clin Res Cardiol. 2013 Sep; 102(9): 661-9. 102. Leick J, Szardien S, Liebetrau C, Willmer M, Fischer-Rasokat U, Kempfert J, Nef H, Rolf A, Walther T, Hamm C, Möllmann H. Mobile left ventricular thrombus in left ventricular dysfunction: case report and review of literature. Clin Res Cardiol. 2013 Jul; 102(7): 479-84. 103. Liebetrau C, Blumenstein J, Rolf A, Kempfert J, Walther T, Hamm C, Möllmann H. Too late, or not too late: that is the question. Thorac Cardiovasc Surg. 2013 Dec; 61(8): 694-5. 104. Liebetrau C, Dörr O, Baumgarten H, Gaede L, Szardien S, Blumenstein J, Rolf A, Möllmann H, Hamm C, Walther T, Nef H, Weber M. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of cardiac surgery associated acute kidney injury. Scand J Clin Lab Invest. 2013 Aug; 73(5): 392-9. 105. Liebetrau C, Möllmann H, Dörr O, Szardien S, Troidl C, Willmer M, Voss S, Gaede L, Rixe J, Rolf A, Hamm C, Nef H. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. J Am Coll Cardiol. 2013 Sep 10; 62(11): 992-8. 106. Liebetrau C, Nef H, Dörr O, Möllmann H. Validität von Biomarkern zur Abschätzung des perioperativen Myokardischämierisikos. Gefässchirurgie. 2013 2013(4): 253-260. 107. Liebetrau C, Nef H, Szardien S, Dörr O, Willmer M, Voss S, Troidl C, Hoffmann J, Rixe J, Rolf A, Hamm C, Möllmann H. Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem. 2013 Mar; 59(3): 566-9. 108. Liosis S, Bauer T, Schiele R, Gohlke H, Gottwik M, Katus H, Sabin G, Zahn R, Schneider S, Rauch B, Senges J, Zeymer U. Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA study. Clin Res Cardiol. 2013 Sep; 102(9): 671-7. 109. Möllmann H, Diemert P, Grube E, Baldus S, Kempfert J, Abizaid A. Symetis ACURATE TF aortic bioprosthesis. EuroIntervention. 2013 Sep 10; 9 Suppl: S107-10. 110. Möllmann H, Kim WK, Walther T, Hamm C. Transkatheteraortenklappenersatz (TAVI). Internist (Berl). 2013 54(12): 1469-1483. 111. Möllmann H, Liebetrau C, Nef H, Kempfert J, Walther T, Hamm C. [Transcutaneous aortic valve implantation]. Internist (Berl). 2013 Jan; 54(1): 28-34, 36-38. 112. Möllmann H, Szardien S, Kempfert J, Nef H, Liebetrau C, Walther T, Hamm C. [Myocardial revascularization]. Herz. 2013 Aug; 38(5): 513-26; quiz 527-8. 113. Parahuleva MS, Ball N, Parviz B, Zandt D, Abdallah Y, Tillmanns H, Hoelschermann H, Kanse SM. Factor seven activating protease (FSAP) expression in human placenta and its role in trophoblast migration. Eur J Obstet Gynecol Reprod Biol. 2013 Mar; 167(1): 34-40. 114. Rolf A, Werner GS, Schuhbäck A, Rixe J, Möllmann H, Nef HM, Gundermann C, Liebetrau C, Krombach GA, Hamm CW, Achenbach S. Preprocedural coronary CT angiography significantly improves success rates of PCI for chronic total occlusion. Int J Cardiovasc Imaging. 2013 Jun 23; 29(8): 1819-1827. 115. Roy DA, Schaefer U, Guetta V, Hildick-Smith D, Möllmann H, Dumonteil N, Modine T, Bosmans J, Petronio AS, Moat N, Linke A, Moris C, Champagnac D, Parma R, Ochala A, Medvedofsky D, Patterson T, Woitek F, Jahangiri M, Laborde JC, Brecker SJ. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol. 2013 Apr 16; 61(15): 1577-84. 116. Sedding DG, Widmer-Teske R, Mueller A, Stieger P, Daniel JM, Gündüz D, Pullamsetti S, Nef H, Moellmann H, Troidl C, Hamm C, Braun-Dullaeus R. Role of the phosphatase PTEN in early vascular remodeling. PLoS One. 2013 8(3): e55445. 117. Shahzad T, Kasseckert SA, Iraqi W, Johnson V, Schulz R, Schlüter KD, Dörr O, Parahuleva M, Hamm C, Ladilov Y, Abdallah Y. Mechanisms involved in postconditioning protection of cardiomyocytes against acute reperfusion injury. J Mol Cell Cardiol. 2013 58(May): 209-16. 118. Shao Y, Redfors B, Scharin Tang M, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Boren J, Omerovic E. Novel rat model reveals important roles of beta-adrenoreceptors in stress-induced cardiomyopathy. Int J Cardiol. 2013 Oct 3; 168(3): 1943-50. 119. Shao Y, Redfors B, Stahlman M, Tang MS, Miljanovic A, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Boren J, Omerovic E. A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy. Eur J Heart Fail. 2013 Jan; 15(1): 9-22. 120. Steg PG, van 't Hof A, Hamm CW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Campo dell' Orto M, Nef H, Steinmetz J, Soulat L, Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M, Goldstein P. Bivalirudin started during emergency transport for primary PCI. N Engl J Med. 2013 Dec 5; 369(23): 2207-17. 121. Streitner F, Hamm K, Wittstein IS, Baranchuk A, Akashi YJ, Nef HM, Bonello L, Wolpert C, Borggrefe M, Haghi D. Is abnormal myocardial repolarization associated with the occurrence of malignant tachyarrhythmias in Takotsubo cardiomyopathy? Cardiol J. 2013 20(6): 633-8. 122. Szardien S, Möllmann H, Willmer M, Akashi YJ, Hamm CW, Nef HM. Mechanisms of stress (takotsubo) cardiomyopathy. Heart Fail Clin. 2013 Apr; 9(2): 197-205. 123. Szardien S, Möllmann H, Willmer M, Liebetrau C, Voss S, Troidl C, Hoffmann J, Rixe J, Elsässer A, Hamm CW, Nef HM. Molecular basis of disturbed extracellular matrix homeostasis in stress cardiomyopathy. Int J Cardiol. 2013 Sep 30; 168(2): 1685-8. 124. Troidl C, Jung G, Troidl K, Hoffmann J, Möllmann H, Nef H, Schaper W, Hamm CW, SchmitzRixen T. The temporal and spatial distribution of macrophage subpopulations during arteriogenesis. Curr Vasc Pharmacol. 2013 Jan; 11(1): 5-12. 125. Van Linden A, Blumenstein J, Walther T, Möllmann H, Kim WK, Hamm C, Kempfert J. Rescue valve-in-valve implantations in second generation transapical transcatheter aortic valve prostheses. Clin Res Cardiol. 2013 Mar; 102(3): 241-3. 126. Weber M, Luchner A, Seeberger M, Mueller C, Liebetrau C, Schlitt A, Apostolovic S, Jankovic R, Bankovic D, Jovic M, Mitrovic V, Nef H, Möllmann H, Hamm CW. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J. 2013 Mar; 34(11): 853-62. 127. Werner N, Bauer T, Hochadel M, Zahn R, Weidinger F, Marco J, Hamm C, Gitt AK, Zeymer U. Incidence and clinical impact of stroke complicating percutaneous coronary intervention: results of the Euro heart survey percutaneous coronary interventions registry. Circ Cardiovasc Interv. 2013 Aug; 6(4): 362-9. 128. Zahn R, Bauer T, Sack FU, Lehman A, Cornelius B, Schiele R. A plea for caution: transcatheter aortic valve implantation using the Medtronic CoreValve prosthesis without balloon predilatation. EuroIntervention. 2013 Sep; 9(5): 654. 129. Zahn R, Erbel R, Nienaber CA, Neumann FJ, Nef H, Eggebrecht H, Senges J. Endovascular aortic repair of thoracic aortic disease: early and 1-year results from a German multicenter registry. J Endovasc Ther. 2013 Jun; 20(3): 265-72. 130. Zahn R, Schiele R, Zeymer U, Bauer T, Lehmann A, Cornelius B, Sack FU. Occlusion of the left main stem: a rare, but life-threatening complication of transcatheter aortic valve implantation with the Medtronic CoreValve prosthesis. Clin Res Cardiol. 2013 Apr; 102(4): 323-6. 2012 (26) 131. Appukuttan A, Kasseckert SA, Micoogullari M, Flacke JP, Kumar S, Woste A, Abdallah Y, Pott L, Reusch HP, Ladilov Y. Type 10 adenylyl cyclase mediates mitochondrial Bax translocation and apoptosis of adult rat cardiomyocytes under simulated ischaemia/reperfusion. Cardiovasc Res. 2012 Feb 1; 93(2): 340-9. 132. Aslam M, Pfeil U, Gündüz D, Rafiq A, Kummer W, Piper HM, Noll T. Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers. Br J Pharmacol. 2012 Jan; 165(1): 208-22. 133. Baldus S, Schillinger W, Franzen O, Bekeredjian R, Sievert H, Schofer J, Kuck KH, Konorza T, Möllmann H, Hehrlein C, Ouarrak T, Senges J, Meinertz T. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 2012 Sep; 14(9): 1050-5. 134. Basic D, Möllmann H, Haas MA, Rolf A, Jovanovic A, Liebetrau C, Szardien S, Leick J, Dörr O, Skwara A, Walther T, Hamm CW, Nef HM. A TASH experience: post-infarction myocardial oedema necessitating the support of ECMO and occurrence of significant mitral regurgitation. Clin Res Cardiol. 2012 Feb; 101(2): 149-53. 135. Bauer T, Möllmann H, Zeymer U, Hochadel M, Nef H, Weidinger F, Zahn R, Hamm CW, Marco J, Gitt AK. Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry. Heart Vessels. 2012 Sep; 27(5): 453-9. 136. Bauer T, Zeymer U, Hochadel M, Möllmann H, Weidinger F, Zahn R, Nef HM, Hamm CW, Marco J, Gitt AK. Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry). Am J Cardiol. 2012 Apr 1; 109(7): 941-6. 137. Blumenstein J, Van Linden A, Arsalan M, Moellmann H, Liebetrau C, Walther T, Kempfert J. Transapical access: current status and future directions. Expert Rev Med Devices. 2012 Jan; 9(1): 15-22. 138. Blumenstein J, Van Linden A, Arsalan M, Voss S, Moellmann H, Liebetrau C, Thourani VH, Walther T, Kempfert J. Experimental evaluation of a new apical access and closure device. Ann Thorac Surg. 2012 Nov; 94(5): 1706-9. 139. Blumenstein J, Van Linden A, Kempfert J, Kim WK, Liebetrau C, Hamm C, Nef H, Walther T, Moellmann H. Retrograde, transsubclavian implantation of a SAPIEN XT aortic valve prosthesis with the Edwards NovaFlex+ system. Clin Res Cardiol. 2012 Sep; 101(9): 773-5. 140. Damman P, Abdel-Wahab M, Möllmann H, Richardt G, Chevalier B, Barragan P, Tijssen JG, Underwood P, Hamm CW. Comparison of twelve-month outcomes after percutanous coronary intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from the PROENCY (PROmus ENdeavor CYpher) registry. J Invasive Cardiol. 2012 Oct; 24(10): 495502. 141. Daniel JM, Dutzmann J, Bielenberg W, Widmer-Teske R, Gündüz D, Hamm CW, Sedding DG. Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation. Basic Res Cardiol. 2012 107(3): 261. 142. Dörr O, Möllmann H, Achenbach S, Sedding D, Basic D, Liebetrau C, Szardien S, Elsässer A, Roth P, Böning A, Hamm C, Nef HM. Transapical coronary artery intervention: "first-in-man" experience. Circ Cardiovasc Interv. 2012 Jun; 5(3): 446-7. 143. Gündüz D, Aslam M, Krieger U, Becker L, Grebe M, Arshad M, Sedding DG, Härtel FV, Abdallah Y, Piper HM, Voss RK, Noll T. Opposing effects of ATP and adenosine on barrier function of rat coronary microvasculature. J Mol Cell Cardiol. 2012 May; 52(5): 962-70. 144. Kempfert J, Möllmann H, Walther T. Symetis ACURATE TA valve. EuroIntervention. 2012 Sep; 8 Suppl Q: Q102-9. 145. Leick J, Liebetrau C, Szardien S, Willmer M, Rixe J, Nef H, Rolf A, Hamm C, Möllmann H. Percutaneous circulatory support in a patient with cardiac arrest due to acute pulmonary embolism. Clin Res Cardiol. 2012 Dec; 101(12): 1017-20. 146. Leick J, Möllmann H, Hamm C. Prästationäre Diagnostik und Therapie des Akuten Koronarsyndroms-Kooperationen und Netzwerke zur gezielten Therapieeinleitung. Der Klinikarzt. 2012 41(11): 514-521. 147. Liebetrau C, Möllmann H, Nef H, Szardien S, Rixe J, Troidl C, Willmer M, Hoffmann J, Weber M, Rolf A, Hamm C. Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem. 2012 Jun; 58(6): 1049-54. 148. Maxeiner H, Abdallah Y, Kuhlmann CR, Schlüter KD, Wenzel S. Effects of cerivastatin on adrenergic pathways, hypertrophic growth and TGFbeta expression in adult ventricular cardiomyocytes. Eur J Cell Biol. 2012 May; 91(5): 367-74. 149. Möllmann H, Szardien S, Kempfert J, Nef H, Liebetrau C, Walther T, Hamm C. [Myocardial revascularization]. Internist (Berl). 2012 Sep; 53(9): 1063-75; quiz 1076-8. 150. Nef HM, Dörr O, Hamm C. Interventionelle Strategie beim NSTE-ACS-Diagnostik, Risikoabschätzung und optimale Intervention. Der Klinikarzt. 2012 41(11): 542-545. 151. Parahuleva MS, Langanke E, Holschermann H, Parviz B, Abdallah Y, Stracke S, Tillmanns H, Kanse SM. Nicotine modulation of factor VII activating protease (FSAP) expression in human monocytes. J Atheroscler Thromb. 2012 19(11): 962-9. 152. Rixe J, Schuhbaeck A, Liebetrau C, Moellmann H, Nef HM, Szardien S, Brandt R, Schmitt J, Neumann T, Schneider C, Krombach G, Hamm CW, Achenbach S, Rolf A. Multi-detector computed tomography is equivalent to trans-oesophageal echocardiography for the assessment of the aortic annulus before transcatheter aortic valve implantation. Eur Radiol. 2012 Dec; 22(12): 2662-9. 153. Szardien S, Nef HM, Troidl C, Willmer M, Voss S, Liebetrau C, Hoffmann J, Rolf A, Rixe J, Elsässer A, Hamm CW, Möllmann H. Bone marrow-derived cells contribute to cell turnover in aging murine hearts. Int J Mol Med. 2012 Aug; 30(2): 283-7. 154. Szardien S, Nef HM, Voss S, Troidl C, Liebetrau C, Hoffmann J, Rauch M, Mayer K, Kimmich K, Rolf A, Rixe J, Troidl K, Kojonazarov B, Schermuly RT, Kostin S, Elsässer A, Hamm CW, Möllmann H. Regression of cardiac hypertrophy by granulocyte colony-stimulating factorstimulated interleukin-1beta synthesis. Eur Heart J. 2012 Mar; 33(5): 595-605. 155. Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H, Schneider S, Ebelt H, Werdan K, Zeymer U. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial. Am Heart J. 2012 Jun; 163(6): 938-45. 156. Urban D, Härtel FV, Gadiraju K, Gündüz D, Aslam M, Piper HM, Noll T. Extracellular ATP attenuates ischemia-induced caspase-3 cleavage in human endothelial cells. Biochem Biophys Res Commun. 2012 Aug 24; 425(2): 230-6. 2011 (21) 157. Abdallah Y, Kasseckert SA, Iraqi W, Said M, Shahzad T, Erdogan A, Neuhof C, Gündüz D, Schlüter KD, Tillmanns H, Piper HM, Reusch HP, Ladilov Y. Interplay between Ca2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes. J Cell Mol Med. 2011 Nov; 15(11): 2478-85. 158. Aslam M, Gündüz D, Schuler D, Li L, Sharifpanah F, Sedding D, Piper HM, Noll T. Intermedin induces loss of coronary microvascular endothelial barrier via derangement of actin cytoskeleton: role of RhoA and Rac1. Cardiovasc Res. 2011 Nov 1; 92(2): 276-86. 159. Bauer T, Möllmann H, Weidinger F, Zeymer U, Seabra-Gomes R, Eberli F, Serruys P, Vahanian A, Silber S, Wijns W, Hochadel M, Nef HM, Hamm CW, Marco J, Gitt AK. Impact of diabetes mellitus status on coronary pathoanatomy and interventional treatment: insights from the Euro heart survey PCI registry. Catheter Cardiovasc Interv. 2011 Nov 1; 78(5): 702-9. 160. Bauer T, Möllmann H, Weidinger F, Zeymer U, Seabra-Gomes R, Eberli F, Serruys P, Vahanian A, Silber S, Wijns W, Hochadel M, Nef HM, Hamm CW, Marco J, Gitt AK. Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina. Int J Cardiol. 2011 Sep 1; 151(2): 164-9. 161. Boudriot E, Thiele H, Walther T, Liebetrau C, Boeckstegers P, Pohl T, Reichart B, Mudra H, Beier F, Gansera B, Neumann FJ, Gick M, Zietak T, Desch S, Schuler G, Mohr FW. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol. 2011 Feb 1; 57(5): 538-45. 162. Eggebrecht H, Schäfer U, Treede H, Boekstegers P, Babin-Ebell J, Ferrari M, Möllmann H, Baumgartner H, Carrel T, Kahlert P, Lange P, Walther T, Erbel R, Mehta RH, Thielmann M. Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv. 2011 Nov; 4(11): 1218-27. 163. Hamm CW, Nef HM, Rolf A, Möllmann H. Calcium and C-reactive protein hot enough to predict the future? J Am Coll Cardiol. 2011 Mar 29; 57(13): 1465-7. 164. Härle T, Kronberg K, Nef H, Möllmann H, Elsässer A. Inverted Takotsubo cardiomyopathy following accidental intravenous administration of epinephrine in a young woman. Clin Res Cardiol. 2011 May; 100(5): 471-3. 165. Heger J, Warga B, Meyering B, Abdallah Y, Schlüter KD, Piper HM, Euler G. TGFbeta receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release. J Cell Physiol. 2011 Oct; 226(10): 2683-90. 166. Liebetrau C, Szardien S, Rixe J, Woelken M, Rolf A, Bauer T, Nef H, Möllmann H, Hamm C, Weber M. Direct admission versus transfer of AMI patients for primary PCI. Clin Res Cardiol. 2011 Mar; 100(3): 217-25. 167. Meissner J, Nef H, Darga J, Kovacs M, Weber M, Hamm C, Möllmann H, Twerenbold R, Reiter M, Heinisch C, Stelzig C, Reichlin T, Mueller C. Endogenous stress response in Tako-Tsubo cardiomyopathy and acute myocardial infarction. Eur J Clin Invest. 2011 Sep; 41(9): 964-70. 168. Mengden T, Nef H, Liebetrau C, Dörr O, Möllmann H, Hamm C. Neue Entwicklungen in der medikamentösen und interventionellen Hochdrucktherapie. Hessisches Ärzteblatt. 2011 72(11): 677-688. 169. Möllmann H, Liebetrau C, Nef HM, Hamm CW. The Swedish paradox: or is there really no gender difference in acute coronary syndromes? Eur Heart J. 2011 Dec; 32(24): 3070-2. 170. Möllmann H, Nef HM, Voss S, Troidl C, Willmer M, Szardien S, Rolf A, Klement M, Voswinckel R, Kostin S, Ghofrani HA, Hamm CW, Elsässer A. Stem cell-mediated natural tissue engineering. J Cell Mol Med. 2011 Jan; 15(1): 52-62. 171. Möllmann H, Szardien S, Liebetrau C, Elsässer A, Rixe J, Rolf A, Nef H, Weber M, Hamm C. Clinical outcome of patients treated with an early invasive strategy after out-of-hospital cardiac arrest. J Int Med Res. 2011 39(6): 2169-77. 172. Munzel G, Schlier A, Schreckenberg R, Abdallah Y, Schlüter KD. Rat intermedin1-47 does not improve functional recovery in postischemic hearts. Naunyn Schmiedebergs Arch Pharmacol. 2011 Dec; 384(6): 535-42. 173. Rolf A, Assmus B, Schachinger V, Rixe J, Möllmann S, Möllmann H, Dimmeler S, Zeiher AM, Hamm CW, Dill T. Maladaptive hypertrophy after acute myocardial infarction positive effect of bone marrow-derived stem cell therapy on regional remodeling measured by cardiac MRI. Clin Res Cardiol. 2011 Nov; 100(11): 983-92. 174. Schwarz N, Schoenburg M, Möllmann H, Kastaun S, Kaps M, Bachmann G, Sammer G, Hamm C, Walther T, Gerriets T. Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting. Am Heart J. 2011 Oct; 162(4): 756-63. 175. Szardien S, Möllmann H, Voss S, Troidl C, Rolf A, Liebetrau C, Rixe J, Elsässer A, Hamm CW, Nef HM. Elevated serum levels of neuropeptide Y in stress cardiomyopathy. Int J Cardiol. 2011 Feb 17; 147(1): 155-7. 176. Walther T, Möllmann H, van Linden A, Kempfert J. Transcatheter aortic valve implantation transapical: step by step. Semin Thorac Cardiovasc Surg. 2011 Spring; 23(1): 55-61. 177. Weber M, Bazzino O, Navarro Estrada JL, de Miguel R, Salzberg S, Fuselli JJ, Liebetrau C, Woelken M, Moellmann H, Nef H, Hamm C. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J. 2011 Jul; 162(1): 81-8.